在与癌症相关的静脉血栓症上正确应用抗凝疗法
1Department of Internal Medicine, Jeonbuk National University Medical School, 20 Geonji-Ro, Deokjin-Gu, Jeonju, 54907, Republic of Korea. yhimhy@jbnu.ac.kr.
Blood research
|August 2, 2024
概括
直接口服抗凝剂已经改变了与癌症相关的静脉血栓栓塞 (VTE) 治疗. 本综述讨论了癌症患者VTE的最佳抗凝剂选择和管理策略,考虑到出血风险和不断变化的数据.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 与癌症相关的静脉血栓塞栓症 (VTE) 是癌症患者发病和死亡的主要原因.
- 直接口服抗凝剂 (DOACs) 在治疗活跃癌症的VTE方面取得了重大进展.
- 由于出血风险和特定的患者/癌症特征,优化DOAC使用仍然存在挑战.
研究的目的:
- 审查与癌症相关的静脉瘤治疗的现状.
- 讨论抗凝剂,特别是DOACs的最佳选择和剂量.
- 为突出管理特定风险因素的癌症患者的VTE的不断发展的策略.
主要方法:
- 最近研究和临床指南的文献综述.
- 对与癌症相关的VTE的DOAC疗效和安全性数据的分析.
- 在这个人群中探索出血和血栓形成的危险因素.
主要成果:
- DOACs提供了优势,但需要仔细考虑特定癌症 (肠道癌,脑癌,脑癌,血液癌) 和患者因素 (功能障碍,血小板减少) 的出血风险.
- 关于低血栓性负担VTE (例如,分段PE,远端DVT) 的新兴数据需要更新的管理方法.
- 最佳抗凝剂的选择和剂量仍然是积极研究的领域.
结论:
- 与癌症相关的静脉瘤治疗是复杂的,需要个性化的治疗策略.
- 需要进一步的研究来完善高风险癌症患者的抗凝剂选择和剂量.
- 更新的临床实践指南对于解决癌症中VTE不断变化的管理至关重要.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
659
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
659
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:28Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498